UY32991A - Derivados de dihidro pirroloquinolina - Google Patents

Derivados de dihidro pirroloquinolina

Info

Publication number
UY32991A
UY32991A UY0001032991A UY32991A UY32991A UY 32991 A UY32991 A UY 32991A UY 0001032991 A UY0001032991 A UY 0001032991A UY 32991 A UY32991 A UY 32991A UY 32991 A UY32991 A UY 32991A
Authority
UY
Uruguay
Prior art keywords
pirroloquinolina
dihidro
derivatives
compound
salt
Prior art date
Application number
UY0001032991A
Other languages
English (en)
Inventor
Miura Kasei
Nishikimi Yuji
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of UY32991A publication Critical patent/UY32991A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Un compuesto representado por la fórmula (I) . El compuesto de la presente invención o una sal de los anteriores es útil como antagonista del receptor de NK.
UY0001032991A 2009-11-06 2010-11-01 Derivados de dihidro pirroloquinolina UY32991A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009255574 2009-11-06
JP2010094144A JP2013053070A (ja) 2009-11-06 2010-04-15 ジヒドロピロロキノリン誘導体

Publications (1)

Publication Number Publication Date
UY32991A true UY32991A (es) 2011-05-31

Family

ID=43416293

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001032991A UY32991A (es) 2009-11-06 2010-11-01 Derivados de dihidro pirroloquinolina

Country Status (6)

Country Link
US (1) US20110112133A1 (es)
JP (1) JP2013053070A (es)
AR (1) AR078854A1 (es)
TW (1) TW201121967A (es)
UY (1) UY32991A (es)
WO (1) WO2011055810A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11981675B1 (en) 2023-12-12 2024-05-14 King Faisal University Pyrrolo[3,2-C]quinoline-2,3-dione compounds as CK2 inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ550983A (en) * 2004-04-28 2010-08-27 Takeda Pharmaceutical Fused quinoline derivative and use as an NK2 receptor antagonist
WO2008153027A1 (ja) 2007-06-11 2008-12-18 Takeda Pharmaceutical Company Limited ピロロキノリン誘導体およびその用途
TW201024297A (en) * 2008-09-10 2010-07-01 Kalypsys Inc Heterocyclic inhibitors of histamine receptors for the treatment of disease

Also Published As

Publication number Publication date
AR078854A1 (es) 2011-12-07
TW201121967A (en) 2011-07-01
WO2011055810A1 (en) 2011-05-12
JP2013053070A (ja) 2013-03-21
US20110112133A1 (en) 2011-05-12

Similar Documents

Publication Publication Date Title
CU24605B1 (es) Pirimidin-2-il amino-1h-pirazoles útiles como inhibidores de lrrk2
UY32481A (es) Derivados de benzofurano
GT201200230A (es) Inhibidores del virus de la hepatitis c
SV2009003349A (es) Compuestos triciclicos, composiciones y procedimientos
GT201400195A (es) Compuestos de heterociclilo como inhibidores de mek
CR20120659A (es) Derivados de piperidinona como inhibidores mdm2 para el tratamiento de cáncer
ECSP12011573A (es) Compuestos tetracíclicos
CR20140042A (es) Indazoles
CR20130087A (es) Compuestos de espiropiperidina como antagonistas del receptor orl-1
CU20110052A7 (es) Compuestos orgánicos
CR20120295A (es) Triazolopiridinas
CR20140229A (es) Nuevos derivados bicíclicos de dihidroisoquinolin-1-ona
ECSP11011066A (es) Moduladores de aril metil benzoquinazolinona alostéricos positivos del receptor m1
BR112013002182A2 (pt) derivados de quinolina e inibidores de melk contendo os mesmos
BRPI1012770B8 (pt) derivados de tiofeno
CR20140535A (es) Novedosas n-piridinil amidas cíclicas sustituidas como inhibidores de quinasa
CR20120234A (es) Derivados de sulfonamida heterocíclicos útiles como inhibidores de mek
CR20130539A (es) Triazolopiridinas
CR20120637A (es) Triazolopiridinas sustituidas
ES2657549T3 (es) Piridopirazinas sustituidas como nuevos inhibidores de SYK
ECSP11011420A (es) Procedimientos para mejorar la farmacocinética
NI201000035A (es) Derivados de azaciclilisoquinolinona e isoindolinona como antagonistas de histamina-3
UY34251A (es) derivados de isoxazolina como compuestos insecticidas.
CO6300955A2 (es) Derivados de isoquinolinilo e isoindolinilo como antagonistas de la histamina -3
CR20150084A (es) 2-oxo-2,3-dihidro-indoles

Legal Events

Date Code Title Description
104 Application deemed to be withdrawn (no substantive examination fee paid)

Effective date: 20130731